ANI Pharmaceuticals, Inc. (ANIP)
80.92
+2.85
(+3.65%)
USD |
NASDAQ |
Apr 17, 16:00
80.88
-0.04
(-0.05%)
After-Hours: 20:00
ANI Pharmaceuticals SG&A Expense (Quarterly) : 82.79M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Liquidia Corp. | 48.24M |
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| Indivior Pharmaceuticals, Inc. | 189.00M |
| Replimune Group, Inc. | 18.73M |
| ADMA Biologics, Inc. | 24.64M |